Concurrently, some reports also confirmed the high expression of IGF-1R in ESCC and the promotion of proliferation and drug resistance of IGF-1 in esophageal cancer cells [17, 18]. This evidence concerns the gene IGF1R and esophageal squamous cell carcinoma.